App-Quantinova.ai

A hybrid strategy with bioresorbable scaffold and drug coated balloon for complex coronary artery lesions in the same vessel: the No More Metallic Cages Multicenter Experience

Ielasi A - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Expansion of bioresorbable vascular scaffold use to coronary bifurcation lesions: a substudy of the European multicentre GHOST-EU registry

Latib A - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

One-year clinical outcomes after full-plastic jacket bioresorbable scaffold implantation

Kawamoto H - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Clopidogrel bisulfate

Small vessel treatment during PCI: clinical outcomes after use of DES with bioresorbable polymer gradient coating

Wohrle J - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

Evaluation of a thin-strut bioresorbable polymer DES in patients with high risk ACS: data from CENTURY II trial

Iniguez A - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

enABL e-registry: 2 year clinical investigation of novel abluminal coated sirolimus-eluting stent

Dani S - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Direct implantation of rapamycin-eluting stents with bioresorbable drug carrier technology utilising a drug-eluting coronary stent integrated delivery system (IDS): the DIRECT II study

Verheye S - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Rapacan

Morphine is associated with delayed platelet inhibition in patients with STEMI undergoing primary PCI with prasugrel and bivalirudin

Kandan S.R - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Venous thrombosis

Bivalirudin

Clopidogrel loading before or after the start of PCI: impact on periprocedural outcomes in the CHAMPION PHOENIX trial

Steg P.G - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Prehospital administration of P2Y12 inhibitors and early coronary reperfusion in primary PCI: a comparative study

De Backer O - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

A subgroup analysis of the CHAMPION PHOENIX trial assessing the effect of cangrelor to prevent PCI periprocedural complications in stable and ACS patients

Abtan J - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

cangrelor

Post-procedural bivalirudin infusion duration and acute stent thrombosis rates from a large United Kingdom primary angioplasty programme: how long is long enough?

Kinnaird T - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Bivalirudin

Meta-analysis of safety and efficacy of bivalirudin vs heparin with or without routine GPIIb/IIIa inhibitor in patients with acute coronary syndrome

Navarese E.P - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Bivalirudin

Incidence and clinical impact of longitudinal stent deformation after the PROMUS Element platinum chromium-everolimus eluting stent implantation

Hiromasa T - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Promus Element

Thienopyridine therapy beyond one year after sirolimus-eluting stent implantation: impact of stent fracture and peri-stent contrast staining

Fuku Y - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Impact of angiographically visible stent malapposition (peri-stent contrast staining [PSS]) on 5-year clinical and angiographic outcome in consecutive 807 patients with drug-eluting stents

Ozaki Y - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Efficiency of biolimus-eluting stents with biodegradable polymers for the treatment of chronically occluded coronary arteries

Rosenberg M - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Angiographic and clinical results after recanalisation of true coronary chronic total occlusions with the sirolimus-eluting stent with an absorbable polymer

Markovic S - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

sirolimus

Bleeding and stent thrombosis with P2Y12-inhibitors: a collaborative analysis on the role of platelet reactivity for risk stratification after PCI

Aradi D - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Usefulness and success of rotational atherectomy for the treatment of coronary bifurcations

Palazuelos J - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

Bivalirudin

Filters

7277 Abstracts